Adzenys is a flavored amphetamine extended-release orally disintegrating tablet, designed to be more easily taken by children only once a day (usually in the morning).

Adzenys XR-ODT was approved by the U.S.

Food and Drug Administration in January 2016 as a treatment for Attention deficit hyperactivity disorder (ADHD) in children.

Adzenys contains a 3 to 1 ratio of d- to l-amphetamine, a central nervous system stimulant.

It has been approved for treatment of ADHD in children 6 years and older.

Stomach aches, loss of appetite, insomnia, and weight loss are the most common side effects associated with the new drug.

Offering an ADHD drug as a once-a-day chewable is “a recipe for people to request it and then sell it,” said Dr.

Mukund Gnanadesikan, a child and adolescent psychiatrist in private practice in California, complained to STAT, a health and medicine news website.

In an article entitled, “Tasty and easy to take, a new ADHD drug alarms some psychiatrists,” only two psychiatrists spoke out against the drug in the article.

^[1]